|
|
|
Insider
Information: |
Schreiber Alain |
Relationship: |
10% Owner |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
12,051,047 |
|
Indirect Shares
|
11,491,339 |
|
|
Direct
Value |
$34,503,710 |
|
|
Indirect Value
|
$2,631,952 |
|
|
Total
Shares |
23,542,386 |
|
|
Total
Value |
$37,135,662 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Molecular Templates, Inc. |
MTEM |
10% Owner |
2005-10-28 |
136,417 |
2005-10-28 |
3,385,203 |
Premium* |
|
Palatin Technologies Inc |
PTN |
10% Owner |
2005-11-29 |
5,803,972 |
2005-11-29 |
0 |
Premium* |
|
Cadence Pharmaceuticals Inc |
CADX |
Director, 10% Owner |
2007-09-19 |
2,882,269 |
2006-10-30 |
12,500 |
Premium* |
|
Optimer Pharmaceuticals Inc |
OPTR |
Director |
2008-07-18 |
2,500 |
2009-03-04 |
811,998 |
Premium* |
|
Avanir Pharmaceuticals |
AVNR |
10% Owner |
2008-08-06 |
0 |
2009-10-13 |
7,125,754 |
Premium* |
|
Eagle Pharmaceuticals, Inc. |
EGRX |
10% Owner |
|
0 |
2017-05-15 |
155,884 |
Premium* |
|
Immune Design Corp. |
IMDZ |
10% Owner |
2015-05-12 |
1,983,858 |
2015-03-05 |
0 |
Premium* |
|
Urogen Pharma Ltd. |
URGN |
10% Owner |
2017-11-28 |
1,242,031 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2016-09-06 |
4 |
S |
$62.45 |
$1,595,904 |
I/I |
(25,397) |
30,527 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2016-09-07 |
4 |
S |
$62.26 |
$712,379 |
I/I |
(11,442) |
30,452 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2016-09-08 |
4 |
S |
$62.33 |
$2,124,580 |
I/I |
(34,086) |
30,228 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2016-09-21 |
4 |
S |
$66.15 |
$6,603,416 |
I/I |
(99,795) |
29,574 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2016-09-30 |
4 |
S |
$70.06 |
$1,548,326 |
I/I |
(22,100) |
4,373,987 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2016-11-02 |
4 |
S |
$70.00 |
$13,992,635 |
I/I |
(199,600) |
27,474 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2016-11-04 |
4 |
S |
$75.00 |
$3,462,750 |
I/I |
(46,170) |
4,181,446 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2016-11-07 |
4 |
S |
$75.39 |
$379,212 |
I/I |
(5,030) |
4,126,087 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2016-11-09 |
4 |
S |
$75.70 |
$11,818,065 |
I/I |
(148,800) |
3,977,287 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2016-11-10 |
4 |
S |
$85.00 |
$1,614,770 |
I/I |
(18,935) |
26,174 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2016-11-11 |
4 |
S |
$85.00 |
$1,321,835 |
I/I |
(15,551) |
3,944,401 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2017-01-04 |
4 |
S |
$85.16 |
$5,545,108 |
I/I |
(65,114) |
3,879,287 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2017-03-16 |
4 |
S |
$82.08 |
$748,570 |
I/I |
(9,120) |
3,870,167 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2017-03-17 |
4 |
S |
$82.01 |
$3,198,144 |
I/I |
(38,997) |
3,831,170 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2017-03-20 |
4 |
S |
$82.10 |
$4,259,594 |
I/I |
(51,883) |
3,779,287 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2017-03-21 |
4 |
S |
$83.10 |
$41,550 |
I/I |
(500) |
3,778,787 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2017-03-23 |
4 |
S |
$83.01 |
$58,107 |
I/I |
(700) |
3,778,087 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2017-03-27 |
4 |
S |
$83.00 |
$3,272,773 |
I/I |
(39,431) |
24,874 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2017-03-28 |
4 |
S |
$83.02 |
$513,230 |
I/I |
(6,182) |
3,734,174 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2017-03-29 |
4 |
S |
$83.01 |
$5,051,574 |
I/I |
(60,855) |
23,274 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2017-03-30 |
4 |
S |
$83.00 |
$516,509 |
I/I |
(6,223) |
3,669,196 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2017-03-31 |
4 |
S |
$83.02 |
$1,966,661 |
I/I |
(23,689) |
3,645,507 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2017-04-03 |
4 |
S |
$83.13 |
$5,105,845 |
I/I |
(61,420) |
3,584,087 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2017-04-25 |
4 |
S |
$88.34 |
$4,788,482 |
I/I |
(54,180) |
6,777 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
|
2017-04-25 |
4 |
OE |
$0.90 |
$1,852,677 |
I/I |
54,180 |
60,957 |
0 |
- |
|
117 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|